ACE and metabolic syndrome: In addition, BMI, WC, systolic and diastolic blood pressure, duration of hypertension, ALT, AST, TBIL, GGT, UACR, uric acid, D0, MetS rate, the use of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), β-blockers, diuretics, calcium channel blockers (CCBs), aspirin and statins in patients with HTN were significantly higher than those without HTN.